TCRX
TScan Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
TScan Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
TScan Therapeutics, Inc.
0.18
TScan Therapeutics has 2 disclosed suppliers and 2 disclosed customers in SEC filings.
SentenceTo establish our proprietary position, we have filed provisional patent applications and corresponding Patent Cooperation Treaty (PCT), national, and regional applications related to our novel product candidates that are important to our business, and we have exclusively licensed a patent family from the Brigham and Women's Hospital, Inc. (BWH); we may in the future also license or purchase issued patents or pending patent applications filed by others.
TCRX 10-Kaccession 0001193125-26-089884
SentenceWe are a party to technology licenses, including in-license agreements with BWH and PHSA, and we may enter into additional licenses in the future.
TCRX 10-Kaccession 0001193125-26-089884
Linked news
Expected move
No implied move.